Hanke L. Matlung

3.1k total citations · 1 hit paper
37 papers, 1.8k citations indexed

About

Hanke L. Matlung is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hanke L. Matlung has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hanke L. Matlung's work include Immune cells in cancer (13 papers), Phagocytosis and Immune Regulation (11 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers). Hanke L. Matlung is often cited by papers focused on Immune cells in cancer (13 papers), Phagocytosis and Immune Regulation (11 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (9 papers). Hanke L. Matlung collaborates with scholars based in Netherlands, Germany and United States. Hanke L. Matlung's co-authors include Timo K. van den Berg, Katka Szilagyi, Taco W. Kuijpers, Neil Barclay, Louise W. Treffers, Erik N.T.P. Bakker, Ed VanBavel, Ida H. Hiemstra, Carlie J.M. de Vries and Dieke J. van Rees and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Hanke L. Matlung

36 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer

2017 421 citations Hanke L. Matlung, Katka Szilagyi et al. Immunological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanke L. Matlung Netherlands	21	1.1k	611	387	315	165	37	1.8k
Zoltán Jakus Hungary	22	994 0.9×	674 1.1×	532 1.4×	124 0.4×	159 1.0×	41	2.2k
Stephen Wax United States	15	710 0.6×	917 1.5×	200 0.5×	344 1.1×	82 0.5×	27	2.2k
Elizabeth A. Mainolfi United States	15	865 0.8×	478 0.8×	284 0.7×	346 1.1×	169 1.0×	21	2.2k
Fanlei Hu China	27	934 0.8×	503 0.8×	248 0.6×	138 0.4×	62 0.4×	81	1.8k
Ludmila Umansky Germany	18	1.5k 1.3×	634 1.0×	1.3k 3.5×	150 0.5×	264 1.6×	21	2.4k
Birgit Niederreiter Austria	24	662 0.6×	762 1.2×	374 1.0×	94 0.3×	58 0.4×	58	1.8k
Marshall D. Behrens United States	21	1.0k 0.9×	646 1.1×	1.0k 2.7×	184 0.6×	128 0.8×	33	2.0k
Manjula Reddy United States	23	840 0.8×	737 1.2×	719 1.9×	208 0.7×	95 0.6×	39	2.0k
Erika Darrah United States	23	871 0.8×	634 1.0×	335 0.9×	448 1.4×	279 1.7×	62	2.5k

Countries citing papers authored by Hanke L. Matlung

Since Specialization

Citations

This map shows the geographic impact of Hanke L. Matlung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanke L. Matlung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanke L. Matlung more than expected).

Fields of papers citing papers by Hanke L. Matlung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanke L. Matlung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanke L. Matlung. The network helps show where Hanke L. Matlung may publish in the future.

Co-authorship network of co-authors of Hanke L. Matlung

This figure shows the co-authorship network connecting the top 25 collaborators of Hanke L. Matlung. A scholar is included among the top collaborators of Hanke L. Matlung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanke L. Matlung. Hanke L. Matlung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matlung, Hanke L., et al.. (2026). Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell Disease. American Journal of Hematology. 101(4). 718–727.

Brandsma, Eelke, et al.. (2024). An AI ‐based imaging flow cytometry approach to study erythrophagocytosis. Cytometry Part A. 105(10). 763–771. 1 indexed citations

Hoogenboezem, Mark, Nikolina Bąbała, Robin van Bruggen, et al.. (2023). Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes. Frontiers in Immunology. 14. 1105103–1105103. 6 indexed citations

Houdt, Michel van, Karin Schornagel, Paul J.J.H. Verkuijlen, et al.. (2023). SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity. International Journal of Molecular Sciences. 24(24). 17141–17141. 5 indexed citations

Segal, Brahm H., Thejaswini Giridharan, A. Nazmul H. Khan, et al.. (2022). Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells. Immunological Reviews. 314(1). 13–35. 38 indexed citations

Rees, Dieke J. van, Maximilian Brinkhaus, Paul Verkuijlen, et al.. (2021). Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20–opsonized B cells to neutrophil killing. Blood Advances. 6(7). 2156–2166. 19 indexed citations

Rees, Dieke J. van, Lieke M. J. van Zogchel, Karin Schornagel, et al.. (2021). G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment. Journal for ImmunoTherapy of Cancer. 9(5). e002259–e002259. 21 indexed citations

Fagerholm, Susanna C., et al.. (2021). β2 Integrin Signaling Cascade in Neutrophils: More Than a Single Function. Frontiers in Immunology. 11. 619925–619925. 55 indexed citations

Neele, Annette E., Hung‐Jen Chen, Marion J. Gijbels, et al.. (2021). Myeloid Ezh2 Deficiency Limits Atherosclerosis Development. Frontiers in Immunology. 11. 594603–594603. 14 indexed citations

10.

Zhao, Xi, Paul J.J.H. Verkuijlen, Anton T. J. Tool, et al.. (2020). Kindlin3-Dependent CD11b/CD18-Integrin Activation Is Required for Potentiation of Neutrophil Cytotoxicity by CD47–SIRPα Checkpoint Disruption. Cancer Immunology Research. 9(2). 147–155. 30 indexed citations

11.

Kuijpers, Taco W., et al.. (2020). Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance. Frontiers in Immunology. 11. 2100–2100. 74 indexed citations

12.

Treffers, Louise W., Toine ten Broeke, Thies Rösner, et al.. (2019). IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition. Cancer Immunology Research. 8(1). 120–130. 72 indexed citations

13.

Rösner, Thies, Hanke L. Matlung, J.H. Marco Jansen, et al.. (2018). Immune Effector Functions of Human IgG2 Antibodies against EGFR. Molecular Cancer Therapeutics. 18(1). 75–88. 25 indexed citations

14.

Treffers, Louise W., Xi Zhao, Joris van der Heijden, et al.. (2017). Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody‐dependent cellular cytotoxicity towards cancer cells. European Journal of Immunology. 48(2). 344–354. 31 indexed citations

15.

Matlung, Hanke L., Katka Szilagyi, Neil Barclay, & Timo K. van den Berg. (2017). The CD47‐SIRPα signaling axis as an innate immune checkpoint in cancer. Immunological Reviews. 276(1). 145–164. 421 indexed citations breakdown →

16.

Treffers, Louise W., Ida H. Hiemstra, Taco W. Kuijpers, Timo K. van den Berg, & Hanke L. Matlung. (2016). Neutrophils in cancer. Immunological Reviews. 273(1). 312–328. 157 indexed citations

17.

Rees, Dieke J. van, Katka Szilagyi, Taco W. Kuijpers, Hanke L. Matlung, & Timo K. van den Berg. (2016). Immunoreceptors on neutrophils. Seminars in Immunology. 28(2). 94–108. 76 indexed citations

18.

Matlung, Hanke L., Annette E. Neele, Harald C. Groen, et al.. (2012). Transglutaminase activity regulates atherosclerotic plaque composition at locations exposed to oscillatory shear stress. Atherosclerosis. 224(2). 355–362. 23 indexed citations

19.

Bonta, Peter I., Hanke L. Matlung, Mariska Vos, et al.. (2010). Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels. Cardiovascular Research. 87(3). 561–568. 37 indexed citations

20.

Matlung, Hanke L., Harald C. Groen, Judith de Vos, et al.. (2009). Calcification Locates to Transglutaminases in Advanced Human Atherosclerotic Lesions. American Journal Of Pathology. 175(4). 1374–1379. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact